HEXO Corp.'s (TSX: HEXO; NYSE: HEXO) loss expanded in the second quarter of 2020, hurt by significant impairment charges. Hexo posted a
HEXO Corp (HEXO) loss in Q2 widens amid impairment charges
Categories
Medical Cannabis
WeedMD posts wider loss in Q1 but revenue soars 192%
Medical-grade cannabis producer WeedMD Inc. reported a wider loss in the first quarter of 2019 due to higher costs and expenses despite